Formulation development of herbal capsule containing oleoresin of Zingiber officinale extract

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 5, Issue 4, 2013, Pages 439-445

  Tunsirikongkon, Amolnat ^a   Kraisit, Pakorn ^a   Seubsasana, Supawadee ^a   Itharat, Arunporn ^a   Sarisuta, Narong ^b  

^a THAMMASAT UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Adsorbent powder; Calcium carbonate; Capsule; Flow ability; Liquisolid; Zingiber officinale

Indexed keywords

(6) GINGEROL; CALCIUM CARBONATE; CALCIUM PHOSPHATE DIBASIC; CAPSICUM OLEORESIN; ESSENTIAL OIL; FILLER; GINGER EXTRACT; GLIDING AGENT; LACTOSE; MICROCRYSTALLINE CELLULOSE; TALC;

ADSORPTION; ANALYTICAL PARAMETERS; ARTICLE; BULK DENSITY; DENSITY; DRUG CAPSULE; DRUG FORMULATION; DRY POWDER; GEOMETRY; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOISTURE; MORPHOLOGY; NONHUMAN; PARTICLE SIZE; POWDER FLOW; SCANNING ELECTRON MICROSCOPY; TAPPED DENSITY; UNIFORMITY OF WEIGHT;

EID: 84885365509     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Chrubasik S, Pittler MH, Roufogalis BD. Zingiberis rhizoma: A comprehensive review on the ginger effect and efficacy profiles. Phytomedicine 2005; 12: 684-701.
2. Farnsworth NR, Fong HHS, Mahady GB, editors. WHO monographs on selected medicinal plants. Malta: Best-set/Interprint; 1999; 1: 277-287.
3. Tjendraputra E, Tran VH, Liu-Brennan D, Roufogalis BD, Duke CC. Effect of ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells. Bioorg Chem 2001; 29: 156-163.
4. Suekawa M, Ishige A, Yuasa K, Sudo K, Aburada M, Hosoya E. Pharmacological studies on ginger. I. Pharmacological actions of pungent constituents, (6)-gingerol and (6)-shogaol. J Pharmacobiodyn 1984; 7: 836-848.
5. Suekawa M, Aburada M, Hosoya E. Pharmacological studies on ginger. II. Pressor action of (6)-shogaol in anesthetized rats, or hindquarters, tail and esenteric vascular beds of rats. J Pharmacobiodyn 1986a; 9: 842-852.
6. Nikham AR, Sathiyanarayanan L, Mahadik, KR. Mapping pharmacokinetic and tissue distribution profile of [6]-shogaol from ginger oleoresin. Int J Pharm Pharm Sci 2013; 5(1): 185-189.
7. Bhattarai S, Tran VH, Duke CC. The stability of gingerol and shogaol in aqueous solutions. J Pharm Sci 2001; 90: 1658-1664.
8. Chaiyakunapruk N, Kitikannakorn N, Nathisuwan S, Leeprakobboon K, Leelasettagool C. The efficacy of ginger for the prevention of postoperative nausea and vomiting: a meta-analysis. Am J Obstet Gynecol 2006; 194(1): 95-9. Review.
9. Ojewole JA. Analgesic, antiinflammatory and hypoglycaemic effects of ethanol extract of Zingiber officinale (Roscoe) rhizomes (Zingiberaceae) in mice and rats. Phytother Res 2006; 20(9): 764-72.
10. Masuda Y, Kikuzaki H, Hisamoto M, Nakatani N. Antioxidant properties of gingerol related compounds from ginger. Biofactors 2004; 21(1-4): 293-6.
11. Wang CC, Chen LG, Lee LT, Yang LL. Effects of 6-gingerol, an antioxidant from ginger, on inducing apoptosis in human leukemic HL-60 cells. In Vivo 2003; 17(6): 641-5.
12. Sekiwa Y, Kubota K, Kobayashi A. Isolation of novel glucosides related to gingerdiol from ginger and theirantioxidative activities. J Agric Food Chem 2000; 48(2): 373-7.
13. Aeschbach R, Loliger J, Scott BC, Murcia A, Butler J, Halliwell B, Aruoma OI. Antioxidant actions of thymol, carvacrol, 6-gingerol, zingerone and hydroxytyrosol. Food Chem Toxicol 1994; 32(1): 31-6.
14. Gupta S, Ravishankar S. A comparison of the antimicrobial activity of garlic, ginger, carrot, and turmeric pastes against Escherichia coli O157: H7 in laboratory buffer and ground beef. Foodborne Pathog Dis 2005; 2(4): 330-40.
15. Thongson C, Davidson PM, Mahakarnchanakul W, Vibulsresth P. Antimicrobial effect of Thai spices against Listeria monocytogenes and Salmonella typhimurium DT104. J Food Prot 2005; 68(10): 2054-8.
16. Kadnur SV, Goyal RK. Beneficial effects of Zingiber officinale Roscoe on fructose induced hyperlipidemia and hyperinsulinemia in rats. Indian J Exp Biol 2005; 43(12): 1161-4.
17. Bhandari U, Kanojia R, Pillai KK. Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. J Ethnopharmacol 2005; 97(2): 227-30.
18. Al-Amin ZM, Thomson M, Al-Qattan KK, Peltonen-Shalaby R, Ali M. Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. Br J Nutr 2006; 96(4): 660-6.
19. Sekiya K, Ohtani A, Kusano S. Enhancement of insulin sensitivity in adipocytes by ginger. Biofactors 2004; 22(1-4): 153-6.
20. Akhani SP, Vishwakarma SL, Goyal RK. Anti-diabetic activity of Zingiber officinale in streptozotocin-induced type I diabetic rats. J Pharm Pharmacol 2004; 56(1): 101-5.
21. Al-Yahya MA, Rafatullah S, Mossa JS, Ageel AM, Parmar NS, Tariq M. Gastroprotective activity of ginger zingiber officinale rosc., in albino rats. Am J Chin Med 1989; 17(1-2): 51-6.
22. Yamahara J, Mochizuki M, Rong HQ, Matsuda H, Fujimura H. The anti-ulcer effect in rats of ginger constituents. J Ethnopharmacol 1988; 23(2-3): 299-304.
23. Ghayur MN, Gilani AH. Ginger lowers blood pressure through blockade of voltage-dependent calcium channels. J Cardiovasc Pharmacol 2005; 45(1): 74-80.
24. Kimura I, Kimura M, Pancho LR. Modulation of eicosanoid-induced contraction of mouse and rat blood vessels by gingerols. Jpn J Pharmacol 1989; 50(3): 253-61.
25. Willetts KE, Ekangaki A, Eden JA. Effect of a ginger extract on pregnancy-induced nausea: a randomized controlled trial. Aust. N. Z. J. Obstet. Gynaecol. 2003; 43: 139-144.
26. Ernst E, Pittler MH. Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. Br J Anaesth 2000; 84: 367-371.
27. Schmid R, Schick T, Steffen R, Tschopp A Wilk. Comparison of seven commonly used agents for prophylaxis of seasickness. J Travel Med 1994; 1: 203-206.
28. Mintong G, Gunjan K, Wendy W, Yun P, Larry LA. A Prototype Intelligent Hybrid System for Hard Gelatin Capsule Formulation Development. Pharm Tech. 2002: 44-60.
29. Chang RK, Raghavan KS, Hussain MA. A study on gelatin capsule brittleness: moisture transfer between the capsule shell and its content. J Pharm Sci 1998; 87(5): 556-8.
30. Jabbar ASA, Hussein, AA. Formulation and evaluation of piroxicam liquisolid compacts. Int J Pharm Pharm Sci 2013; 5(1): 132-141.
31. th ed. London: Pharmaceutical press; 2009.
32. LandínM et al. Structural changes during the dehydration of dicalcium phosphate dihydrate. Eur J Pharm Sci 1994; 2: 245-252.
33. Landi{dotless}n Met al. Dicalcium phosphate dihydrate for direct compression: characterization and intermanufacturer variability. Int J Pharm 1994; 109: 1-8.
34. Bravo-Osuna I, Ferrero C, Jiménez-Castellanos MR. Influence of moisture content on the mechanical properties of methyl methacrylate-starch copolymers. Eur J Pharm Biopharm. 2007; 66: 63-72.
35. Abdullah EC, Geldart D. The use of bulk density measurements as flow-ability indicators. Powder Technology 1999; 3: 151-165.
36. Abdul Mobeen N. F et al. Effect of moisture and magnesium stearate concentration on flow properties of cohesive granular materials. Int J Pharm 2007; 24: 338-345.